Cargando…

Prognostic value of stem cell markers in esophageal and esophagogastric junction cancer: a meta-analysis

Background: Esophageal cancer is an aggressive tumor, with poor prognosis and low survival rates. Although diagnosis and treatment have improved considerably, more efficient prognostic factors are urgently needed to prevent postoperative recurrence and metastasis. Cancer stem cells are key players i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trevellin, Elisabetta, Pirozzolo, Giovanni, Fassan, Matteo, Vettor, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196270/ https://www.ncbi.nlm.nih.gov/pubmed/32368307 http://dx.doi.org/10.7150/jca.33699

Ejemplares similares

Prognostic Value of Perineural Invasion in Esophageal and Esophagogastric Junction Carcinoma: A Meta-Analysis
por: Gao, Aiqin, et al.
Publicado: (2016)

Blood-based Markers in the Prognostic Prediction of Esophagogastric Junction Cancer
por: Liu, Can-Tong, et al.
Publicado: (2020)

Esophageal Stent for Cervical Esophagus and Esophagogastric Junction
por: Shim, Chan Sup
Publicado: (2012)

Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma
por: Yang, Bo, et al.
Publicado: (2018)

Prognostic Value of Intraoperative Blood Transfusion in Patients with Adenocarcinoma of the Esophagogastric Junction
por: Nakajima, Kei, et al.
Publicado: (2022)

Esophageal adenocarcinoma microenvironment: Peritumoral adipose tissue effects associated with chemoresistance
por: Carraro, Amedeo, et al.
Publicado: (2017)

Esophageal adenocarcinoma and obesity: peritumoral adipose tissue plays a role in lymph node invasion
por: Trevellin, Elisabetta, et al.
Publicado: (2015)

Total Esophageal Avulsion at the Esophagogastric Junction after Blunt Trauma
por: Uygun, Ibrahim, et al.
Publicado: (2013)

Accuracy of the endoscopic evaluation of esophageal involvement in esophagogastric junction cancer
por: Sakai, Takeshi, et al.
Publicado: (2021)

Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma
por: Tokunaga, Ryuma, et al.
Publicado: (2015)

The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction
por: Jomrich, Gerd, et al.
Publicado: (2018)

Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance
por: Mikami, Hironobu, et al.
Publicado: (2018)

Adenocarcinosarcoma at the esophagogastric junction with long esophageal invasion: a case report
por: Furukawa, Kenichiro, et al.
Publicado: (2020)

Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity
por: Turato, Cristian, et al.
Publicado: (2019)

Obesity, the Adipose Organ and Cancer in Humans: Association or Causation?
por: Trevellin, Elisabetta, et al.
Publicado: (2023)

Effects of Metoclopramide on Esophageal Motor Activity and Esophagogastric Junction Compliance in Healthy Volunteers
por: Mikami, Hironobu, et al.
Publicado: (2016)

The Evaluation of Esophageal Endoscopic Findings in Patients with Functional Esophagogastric Junction Outflow Obstruction
por: Ochiai, Yorinari, et al.
Publicado: (2021)

Prognostic Importance of the Preoperative Naples Prognostic Score for Patients With Adenocarcinoma of the Esophagogastric Junction
por: Xiong, Jianping, et al.
Publicado: (2020)

Hypotonic Upper Esophageal Sphincter With Functional Esophagogastric Junction Obstruction in a Patient With Oropharyngeal and Esophageal Dysphagia
por: Park, Moo In
Publicado: (2011)

The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma
por: Li, Zheng, et al.
Publicado: (2021)

Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction
por: Sun, Lidan, et al.
Publicado: (2014)

Prognostic Significance of Esophagogastric Junction Invasion in Patients with Adenocarcinoma of the Cardia or Subcardia
por: Oh, Sung Eun, et al.
Publicado: (2023)

Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction
por: Cai, Ming-Zhi, et al.
Publicado: (2019)

Comparative efficacy of treatments for previously treated patients with advanced esophageal and esophagogastric junction cancer: A network meta-analysis
por: Lin, Shuiyu, et al.
Publicado: (2021)

Clinical significance of signet ring cells in surgical esophageal and esophagogastric junction adenocarcinoma: A systematic review and meta-analysis
por: Wang, Yi-Fan, et al.
Publicado: (2021)

Short‐term postoperative complications and prognostic factors in patients with adenocarcinoma of the esophagogastric junction
por: Zhang, Hui, et al.
Publicado: (2018)

Trends in esophageal and esophagogastric junction cancer research from 2007 to 2016: A bibliometric analysis
por: Miao, Yan, et al.
Publicado: (2017)

Impact of Weight Loss on Patients with Locally Advanced Esophageal and Esophagogastric Junction Cancers Treated with Chemoradiotherapy
por: Wiwitkeyoonwong, Jirapath, et al.
Publicado: (2021)

Esophageal Bolus Domain Pressure and Peristalsis Associated With Experimental Induction of Esophagogastric Junction Outflow Obstruction
por: Lei, Wei-Yi, et al.
Publicado: (2022)

Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction
por: Kamiya, Hajime, et al.
Publicado: (2023)

The combination of preoperative fibrinogen and neutrophil-lymphocyte ratio is a predictive prognostic factor in esophagogastric junction and upper gastric cancer
por: Cong, Xiliang, et al.
Publicado: (2019)

Current surgical treatment of esophagogastric junction adenocarcinoma
por: Zhang, Shun, et al.
Publicado: (2019)

Esophagogastric Junction Outflow Obstruction Caused by Gabapentin
por: Barret, Maximilien, et al.
Publicado: (2019)

Integrative proteomic characterization of adenocarcinoma of esophagogastric junction
por: Li, Shengli, et al.
Publicado: (2023)

Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma
por: Xu, Yi-Wei, et al.
Publicado: (2019)

The Impact of Magnetic Sphincter Augmentation (MSA) on Esophagogastric Junction (EGJ) and Esophageal Body Physiology and Manometric Characteristics
por: Ayazi, Shahin, et al.
Publicado: (2023)

Prognostic Significance of CIP2A in Esophagogastric Junction Adenocarcinoma: A Study of 65 Patients and a Meta-Analysis
por: Li, Yanhong, et al.
Publicado: (2019)

Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction
por: Aratani, Kenichi, et al.
Publicado: (2017)

Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction
por: Zhou, Zhangjian, et al.
Publicado: (2015)

Role of Nampt and Visceral Adiposity in Esophagogastric Junction Adenocarcinoma
por: Li, Haijun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fm6hhlqkfu1fge38b2hjam3luo